Naveh Pharma LTD   Report issue

For profit Phase 3
Founded: Netanya Israel (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2018
NCT03807219
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Naveh Pharma (1996) Ltd. | Naveh Pharma LTD

Active Ingredients

Drugs in Phase 3 Trials (1)

magnesium oxide (1 trial)

Drugs in Other Trials (3)

magnesium (1 trial)

pyridoxine (1 trial)

vitamin e (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Heart Failure (Phase 3)

Magnesium Deficiency (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4